Abstract.
Objective and Design: The ability of azaspiranes to modulate the acute inflammatory response in models of skin inflammation was examined.¶Material: The in vivo experiments involved the use of 5–6 age-matched male Balb/c inbred mice (22–25 g) per treatment group and a control group of 8–10 animals. In vitro mechanistic studies used RBL-1 and U937 cells lines and freshly isolated human monocytes.¶Treatment: Arachidonic acid (AA) (2 mg/20 ul in acetone) or PMA (phorbol myristate acetate) (4 ug/20 ul) were applied topically. SK&F 106615 and SK&F 106610 were administered topically either dissolved in acetone or dimethylacetamide just after the application of the irritant. Isolated cells were treated with the compounds dissolved in DMSO.¶Methods: The thickness and influx of neutrophils into the treated ears was measured as was the effects of the azaspiranes on 5-lipoxygenase activity, cyclooxygenase activity, prostaglandin and leukotriene synthesis, and the activation of the transcription factor NF-κB.¶Results: SK&F 106615 and SK&F 106610 significantly reduced inflammation in the AA- and PMA-induced inflammation models (p < 0.05) with ED50's of 179 and 120 mg/ear for edema and myeloperoxidase, respectively. The compounds did not inhibit eicosanoid biosynthesis, have a direct effect on 5-lipoxygenase or cyclooxygenase enzymes, or inhibit NF-κB.¶Conclusions: The potent anti-inflammatory and immunomodulatory activities of the azaspiranes observed in these and other studies appear to be mediated by a novel mechanism.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 29 July 1997; returned for revision 27 September 1997; accepted by G. Letts 12 November 1997
Rights and permissions
About this article
Cite this article
Griswold, D., Martin, L., Badger, A. et al. Evaluation of the cutaneous anti-inflammatory activity of azaspiranes. Inflamm. res. 47, 56–61 (1998). https://doi.org/10.1007/s000110050270
Published:
Issue Date:
DOI: https://doi.org/10.1007/s000110050270